rs3811613

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_012293.3(PXDN):​c.2892C>T​(p.Asn964Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.287 in 1,601,446 control chromosomes in the GnomAD database, including 67,217 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4947 hom., cov: 32)
Exomes 𝑓: 0.29 ( 62270 hom. )

Consequence

PXDN
NM_012293.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0450

Publications

16 publications found
Variant links:
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
PXDN Gene-Disease associations (from GenCC):
  • anterior segment dysgenesis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 2-1648888-G-A is Benign according to our data. Variant chr2-1648888-G-A is described in ClinVar as [Benign]. Clinvar id is 260224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.045 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PXDNNM_012293.3 linkc.2892C>T p.Asn964Asn synonymous_variant Exon 17 of 23 ENST00000252804.9 NP_036425.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PXDNENST00000252804.9 linkc.2892C>T p.Asn964Asn synonymous_variant Exon 17 of 23 1 NM_012293.3 ENSP00000252804.4 Q92626-1
PXDNENST00000478155.5 linkn.2697-4136C>T intron_variant Intron 9 of 14 2

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37341
AN:
151770
Hom.:
4951
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.239
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.301
Gnomad OTH
AF:
0.242
GnomAD2 exomes
AF:
0.278
AC:
64544
AN:
232446
AF XY:
0.284
show subpopulations
Gnomad AFR exome
AF:
0.142
Gnomad AMR exome
AF:
0.236
Gnomad ASJ exome
AF:
0.282
Gnomad EAS exome
AF:
0.269
Gnomad FIN exome
AF:
0.252
Gnomad NFE exome
AF:
0.301
Gnomad OTH exome
AF:
0.290
GnomAD4 exome
AF:
0.292
AC:
422585
AN:
1449558
Hom.:
62270
Cov.:
72
AF XY:
0.294
AC XY:
211512
AN XY:
720626
show subpopulations
African (AFR)
AF:
0.144
AC:
4797
AN:
33400
American (AMR)
AF:
0.233
AC:
10300
AN:
44176
Ashkenazi Jewish (ASJ)
AF:
0.282
AC:
7338
AN:
25994
East Asian (EAS)
AF:
0.259
AC:
10246
AN:
39510
South Asian (SAS)
AF:
0.318
AC:
27242
AN:
85644
European-Finnish (FIN)
AF:
0.258
AC:
11869
AN:
46044
Middle Eastern (MID)
AF:
0.336
AC:
1933
AN:
5754
European-Non Finnish (NFE)
AF:
0.299
AC:
331608
AN:
1108956
Other (OTH)
AF:
0.287
AC:
17252
AN:
60080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
21858
43716
65573
87431
109289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10874
21748
32622
43496
54370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.246
AC:
37332
AN:
151888
Hom.:
4947
Cov.:
32
AF XY:
0.244
AC XY:
18084
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.146
AC:
6061
AN:
41456
American (AMR)
AF:
0.241
AC:
3684
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
948
AN:
3472
East Asian (EAS)
AF:
0.270
AC:
1366
AN:
5064
South Asian (SAS)
AF:
0.311
AC:
1493
AN:
4808
European-Finnish (FIN)
AF:
0.239
AC:
2524
AN:
10558
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.301
AC:
20437
AN:
67916
Other (OTH)
AF:
0.243
AC:
515
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1418
2836
4253
5671
7089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.284
Hom.:
12282
Bravo
AF:
0.241
Asia WGS
AF:
0.295
AC:
1026
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Anterior segment dysgenesis 7 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
4.4
DANN
Benign
0.80
PhyloP100
0.045
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3811613; hg19: chr2-1652660; COSMIC: COSV53229291; COSMIC: COSV53229291; API